financial guidance
DiaSorin Q2 Revenues Rise 20 Percent on SARS-CoV-2 Testing Demand
DiaSorin posted Q2 molecular revenues of €69.4 million, up 23 percent year over year from €56.6 million.
Siemens Healthineers Q3 Diagnostics Revenues Almost Double on Rapid Antigen Test Demand
The firm reported total revenues rose 51 percent year over year to €5.00 billion and said full-year 2021 revenues are expected to be up 17 to 19 percent.
Qiagen Q2 Revenues Grow 28 Percent
For the three months ended June 30, Qiagen reported total revenues of $567.3 million, in line with preliminary numbers provided earlier this month.
CareDx Q2 Revenues up 77 Percent
The company reported $74.2 million in total revenues for the quarter and said testing service revenues rose 79 percent year over year.
Exact Sciences Q2 Revenues Rise 62 Percent
The company said screening revenues in Q2, from Cologuard tests and Biomatrica products, doubled year over year.
Jul 28, 2021
Thermo Fisher Scientific Q2 Revenues up 34 Percent
May 11, 2021
Exagen Q1 Revenues Grow 10 Percent
May 10, 2021
Castle Biosciences Q1 Revenues Up 31 Percent
May 6, 2021
Natera Q1 Revenues Grow 62 Percent
May 5, 2021
CareDx Q1 Revenues up 76 Percent
May 3, 2021
Qiagen Q1 Revenues Jump 52 Percent
Apr 22, 2021